Interventional Latest News Archive
The Eluvia stent is designed to release paclitaxel for a 1-year time frame to prevent tissue regrowth that might otherwise block the stented artery.
HbA1c levels following left ventricular assist device implantation were statistically significantly lower than before surgery.
The Agency reviewed real-world data from 80 patients who received the PK Papyrus Stents, finding that the stents were delivered successfully to the perforation site in 95% of patients with successful seals seen in 73 patients 91.3% of patients.
Surgical and transcatheter aortic valve replacement had a similar risk for adverse outcomes in patients with severe aortic stenosis, regardless of whether or not the patients had prior cardiac surgery.
Ticagrelor without aspirin offered no additional benefits compared with conventional dual antiplatelet therapy in patients undergoing PCI for either CAD or ACS.
Net adverse cardiac events occurred in 15.2% of patients with radial access and 17.2% with femoral access while undergoing invasive therapies for acute coronary syndrome.
Tissue adhesive with polyurethane dressing, bordered polyurethane dressing, or using a securement device with polyurethane dressing were not superior to standard low-cost polyurethane dressing for peripheral intravenous catheters.
Patients with higher levels of thyroid-stimulating hormone were more likely to experience atrial tachyarrhythmia after catheter ablation for atrial fibrillation.
The SYNTAX score II was an independent predictor of mortality in patients with 1- and 2-vessel disease undergoing percutaneous coronary intervention.
Patients with leadless cardiac pacemakers experienced fewer short-term and midterm complications, but more pericardial effusions than patients with standard transvenous pacemakers.
High platelet reactivity was associated with an increased risk for ischemic stroke in patients who had undergone drug-eluting stent implantation.
Individuals who required a permanent pacemaker after transcatheter aortic valve replacement had an increased risk for mortality and hospital readmissions.
Precapillary pulmonary hypertension and obstructive sleep apnea may be causative factors for central sleep apnea and pulmonary hypertension, respectively.
The HeartMate 3™ Left Ventricular Assist System has been recalled because of a potential malfunction in the outflow graft assembly that may cause it to twist and close up over time.
The use of 3D-printed models is transforming congenital heart disease care by improving clinical outcomes and medical training.
Ticagrelor plus aspirin was superior in increasing post-coronary artery bypass grafting patency compared with aspirin alone.
In patients with COPD, transcatheter aortic valve replacement was associated with fewer respiratory-related complications than surgical aortic valve replacement.
Major adverse cardiovascular events were not reduced in patients with acute coronary syndrome undergoing planned percutaneous coronary intervention when given 2 loading doses of atorvastatin.
Aim of study was to determine whether treatment with percutaneous coronary intervention or coronary artery bypass grafting leads to improved outcomes in patients with diabetes, coronary artery disease, and left ventricular dysfunction.
The smartphone heart rate monitoring application had higher diagnostic accuracy compared with standard physical examination for determining ulnar artery patency prior to radial access.
Patients with pulmonary hypertension have a high risk for adverse events during and following cardiac catheterization, but high case volume may help ameliorate this risk.
Patent foramen ovale closure resulted in a lower recurrence of stroke in patients with cryptogenic stroke and high-risk PFO characteristics.
The FDA has approved a new size of the Masters Series Mechanical Heart Valve with Hemodynamic Plus Sewing Cuff for use in newborn patients with heart defects.
Abnormal glucose metabolism may be present in patients with undetected diabetes after percutaneous coronary intervention.
A shared decision-making program between patients with end-stage heart failure being considered for destination therapy left ventricular assist device and their caregivers was associated with improvement in patient knowledge.
Percutaneous closure of patent foramen ovale is not associated with a reduction in migraine headaches in patients with and without aura.
Thrombocytopenia at hospital admission may be an independent predictor for in-hospital mortality in patients with rheumatic heart disease undergoing valve replacement surgery.
Patients with multivessel coronary artery disease and diabetes may benefit more from coronary artery bypass grafting surgery vs percutaneous coronary intervention.
Endovascular strategy is associated with better survival rate and decreased hospital costs compared to open repair in ruptured abdominal aortic aneurysm.
Intravenous sodium bicarbonate is not superior to intravenous sodium chloride for reducing acute kidney injury during angiography.
No evidence shows efficacy of PCI procedures for patients with stable coronary artery disease with angina.
Patients who received bioresorbable vascular scaffolds had higher rates of device thrombosis and target vessel MI compared with those who received everolimus-eluting stents.
Researchers analyzed 3-year outcomes in patients implanted with bioresorbable vascular scaffolds for the treatment of coronary lesions.
A substudy analyzed whether PCI outcomes using second generation drug eluting stents were comparable to CABG in patients with low or intermediated complexity left main coronary artery disease.
Change in inducibility status after pulmonary vein isolation is not associated with long-term freedom from recurrent arrhythmia.
Patients with atrial fibrillation had improved late survival when treated with ablation-assisted Cox-Maze IV and cardiac surgery.
The FDA approved the Confirm Rx insertable cardiac monitor, which is implanted under the skin in a minimally-invasive outpatient procedure.
Patients with heart failure who received transcatheter aortic valve replacements saw decrease in aortic valve mean gradient.
A first-line contact aspiration technique demonstrates no significant benefit over the stent retriever technique in achieving revascularization in patients with acute ischemic stroke.
Patients with atrial fibrillation who are at a low risk for stroke do not receive a major benefit from long-term aspirin therapy.
Pulmonary endarterectomy is an effective treatment for patients with chronic thromboembolic pulmonary hypertension.
In patients undergoing percutaneous coronary intervention for either STEMI or NSTEMI, bivalirudin and heparin produce similar outcomes.
Coronary artery bypass grafting yielded better outcomes in patients with type 1 diabetes who had multivessel disease compared with percutaneous coronary intervention.
A new pericardial aortic surgical valve has received US Food and Drug Administration and European Commission approval.
The delivery wire component of the Penumbra 3D revascularization device may break or separate during use.
The FDA approved a new pericardial aortic valve for replacement of native or prosthetic valves.
The Essential Frailty Toolset is a fast and effective predictor of death and worsening disability following valve replacement.
Bristol-Myers Squibb is recalling one lot of Eliquis after finding that 1 of the bottles contained the wrong dosage.
The American Association for Thoracic Surgery has developed evidence-based guidelines on the use of surgical ablation for atrial fibrillation.
The response to endovascular treatment for acute ischemic stroke after 2 years was as good as in the first 90 days.
Patients with HbA1c levels had lower 7-year incidence of major adverse cardiac and cerebrovascular events compared with patients with higher HbA1c levels.
The effect of hypoglycemia on functional outcomes after endovascular thrombectomy differs, depending on collateral status.
Both iFR and FFR groups experienced similar rates of composite nonfatal myocardial infarction, unplanned revascularization, or all-cause death within 1 year post-procedure.
Revised coronary revascularization criteria rated whether coronary interventions are appropriate in tables organized according to practice patterns.
Target lesion failure was 5.8% at 1 year after implantation with the SYNERGY stent.
After 5 years, the cumulative incidence of MACE was 6.7% in the everolimus-eluting stent group and 11.2% in the sirolimus-eluting stent group.
At 2 years, the estimated incidence of the primary end point was 12.6% in the TAVR group vs 14% in the surgery group.
Survival rates were high for patients with both central and peripheral pulmonary emboli.
Stroke treatment delays were attributed to inability of the care team to determine patient eligibility, hypertension needing aggressive treatment, and in-hospital delays.
Contact aspiration and stent retriever approaches for mechanical thrombectomy achieved similar efficacy and safety end points.
Standardized definitions for neurologic injury, such as stroke, hypoxic-ischemic injury, and cerebral hemorrhage were proposed by the NeuroARC initiative.
No major differences in MACE or stent thrombosis were shown between the 2 drug-eluting stents after 10 years of follow-up.
Three revascularization techniques were compared in patients with concomitant carotid and coronary artery disease undergoing CABG.
When ultraviolet was added to the reference disinfection method, the incidence of target organisms was reduced by 30%.
Periprocedural Anticoagulation in Atrial Fibrillation: American College of Cardiology Decision Pathway
The American College of Cardiology released a decision pathway for managing periprocedural anticoagulation in patients with nonvalvular atrial fibrillation
Significantly decreased platelet reactivity occurred in patients who were given a new statin or an increased dose of a previous statin.
To reduce the incidence of systemic inflammatory response syndrome in pediatric patients after heart surgery, researchers suggest restricting blood product use.
Higher SYNTAX scores may predict major cardiovascular events in patients with coronary artery disease and diabetes.
The left atrial appendage closure device was found to have excellent success and low complication rates in a post-FDA approval study.
The American College of Cardiology has released guidelines for determining if patients with aortic stenosis are appropriate candidates for transcatheter aortic valve replacement.
No significant differences were observed between dual antiplatelet therapy and aspirin alone following coronary artery bypass grafting in patients with diabetes.
Although current guidelines recommend delaying noncardiac surgery for 6 to 12 months after drug-eluting stent implantation, new data suggest surgery may be performed earlier.
Although female patients experienced higher in-hospital vascular complications, their overall 1-year survival rates were better.
Endovascular therapy was considered noninferior to bypass surgery in patients with critical limb ischemia.
After multivariate adjustment, no significant in-hospital mortality difference was found between centers with and without on-site cardiac surgery.
A real-world study of fractional flow-reserve-guided revascularization in coronary artery disease identified several concerns with use of the technique.
All-cause death plus hospitalization possibly from bleeding were reduced in both rivaroxaban groups compared with the reference group.
At 1 year, primary patency was 82.3% for the drug-coated balloon group vs 70.9% for the percutaneous transluminal angioplasty group.
Procedural data from the WATCHMAN clinical trial presented at TCT demonstrated the device implantation success rate in patients with nonvalvular atrial fibrillation.
The Sentinel transcatheter cerebral embolic protection device was safe and captured 99% of debris in patients undergoing TAVR.
Transcatheter aortic valve replacement with SAPIEN valve demonstrates long-term durability and improves quality of life.
The 1-year target lesion failure was 8.3% for patients with diabetes which was significantly lower than the pre-specified goal of 12.7%.
Patients with new-onset atrial fibrillation after CABG experience higher rates of morbidity and poor long-term survival outcomes compared to women.
Patients undergoing left main PCI treated by high-volume operators had a significantly lower risk for short- and long-term cardiac death compared with those treated by less experienced operators.
The use of embolic protection during TAVR was associated with a lower total lesion volume and fewer new ischemic lesions.
Patients who underwent intravascular ultrasound guided drug-eluting stent implantation vs angiography-guided implantation had reductions in MACE.
Using primary percutaneous coronary intervention or a pharmacoinvasive strategy results in similar outcomes for patients with STEMI.
PCI in patients with chronic total occlusion of the left anterior descending coronary artery had significantly improved LVEF compared with control patients.
Late mortality after transcatheter aortic valve replacement was mostly due to noncardiac causes.
The rate of radial artery occlusion at 30 days after catheterization was significantly lower in patients who received prophylactic ipsilateral ulnar compression.
Cardiac recovery was independently predicted by age, nonischemic cardiomyopathy, time from cardiac diagnosis, lack of ICD, serum creatinine levels, and LV end-diastolic dimensions.
Women with moderate or severe coronary artery calcification had higher risks of death, MI, or target revascularization, despite new-generation drug-eluting stents.
Cangrelor provided similar perioprocedural benefits, as well as reduced risk of bleeding, as clopidogrel in patients with stable angina and acute coronary syndromes.
Obese patients were at increased risk of death compared with patients of normal weight.
Study reveals incidence, risk factors, and clinical characteristics of transcatheter aortic heart valve thrombosis after TAVR.
Patients with a history of atrial fibrillation were more likely to have postprocedural bleeding, blood transfusion, heart failure, cardiogenic shock, and in-hospital mortality.
Two clinical studies were conducted to assess safety and effectiveness in patients with aortic stenosis at intermediate risk.
No differences between monotherapy and multiple anthrombotic therapy in rates of stroke, MACE, or death.
Researchers observed a "significant inverse correlation" between P2Y12 reaction units and hemoglobin.
No reduction in cardiovascular morbidity or mortality at 30-day and 3-year follow-up.
The Cardiology Advisor Articles
- Cardiac Troponin Elevation Predicts Major Adverse Events Even Without Specific Diagnosis
- How Has the Medicaid Expansion Affected Patients Hospitalized With Acute MI?
- Macitentan Not Superior to Placebo for Improving Exercise Capacity in Eisenmenger Syndrome
- Association Between Statins and Depression Likely Mediated by Confounding
- Occupational Metal, Pesticide Exposure May Be Associated With Increased CVD Risk
- ASH Develops Practice Guidelines for Venous Thromboembolism
- Tetralogy of Fallot: Long-Term Outcomes After Surgical Repair
- Cardiac Troponin Elevation Predicts Major Adverse Events Even Without Specific Diagnosis
- Catheter Ablation Superior to Drug Therapy for Atrial Fibrillation in Heart Failure
- Trends in Endocarditis Incidence After Implementation of 2007 AHA Recommendations
- Researchers Identify Golden Ratio Between Pulmonary Pressure Components in PAH
- FDA: Potential Increased Mortality With Paclitaxel-Coated Balloons, Stents for PAD
- Inhaled Dry Powder Formulation of Treprostinil Well Tolerated in PAH
- Elevated Myocardial T1 Associated With Increased Septal Angle in PAH
- Pulmonary Hypertension Intensive Care Options Depend on Treatment Goals